首页 / 院系成果 / 成果详情页

Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles 期刊论文 WOS高被引论文

编号：

41cc0361-99ae-4c94-887e-55cb09a49f06
作者：

Wang, Hai(王海)#^[1]Zhao, Ying^[1];Wu, Yan^[1];Hu, Yulin(胡玉琳)^[2]Nan, Kaihui^[3];Nie, Guangjun(聂广军)*^[1]Chen, Hao(陈浩)*^[3]
语种：

英文
期刊：

BIOMATERIALS ISSN：0142-9612 2011 年 32 卷 32 期 (8281 - 8290) ; NOV
收录：
关键词：

Nanotechnology Co-delivery of drugs Multifunctional nanoparticles Double emulsion Controlled drug release
摘要：

The use of single chemotherapeutic drug has shown some limitations in anti-tumor treatment, such as development of drug resistance, high toxicity and limited regime of clinical uses. The combination of two or more therapeutic drugs is feasible means to overcome the limitations. Co-delivery strategy has been proposed to minimize the amount of each drug and to achieve the synergistic effect for cancer therapies. Attempts have been made to deliver chemotherapeutic drugs simultaneously using drug carriers, such as micelles, liposomes, and inorganic nanoparticles (NPs). Here we reported core-shell NPs that were doubly emulsified from an amphiphilic copolymer methoxy poly(ethylene glycol)-poly(lactide-co-glycolide) (mPEG-PLGA). These NPs offered advantages over other nanocarriers, as they were easy to fabricate by improved double emulsion method, biocompatible, and showed high loading efficacy. More importantly, these NPs could co-deliver hydrophilic doxorubicin (DOX) and hydrophobic paclitaxel (TAX). The drug-loaded NPs possessed a better polydispersity, indicating that they are more readily subject to controlled size distribution. Studies on drug release and cellular uptake of the co-delivery system demonstrated that both drugs were effectively taken up by the cells and released simultaneously. Furthermore, the co-delivery nanocarrier suppressed tumor cells growth more efficiently than the delivery of either DOX or TAX at the same concentrations, indicating a synergistic effect. Moreover, the NPs loading drugs with a DOX/TAX concentration ratio of 2:1 showed the highest anti-tumor activity to three different types of tumor cells. This nanocarrier might have important potential in clinical implications for co-delivery of multiple anti-tumor drugs with different properties. (C) 2011 Elsevier Ltd. All rights reserved.
推荐引用方式
GB/T 7714：

Wang Hai,Zhao Ying,Wu Yan, et al. Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles [J].BIOMATERIALS,2011,32(32):8281-8290.
APA：

Wang Hai,Zhao Ying,Wu Yan,Hu Yu-lin,&Chen Hao.(2011).Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles .BIOMATERIALS,32(32):8281-8290.
MLA：

Wang Hai, et al. "Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles" .BIOMATERIALS 32,32(2011):8281-8290.
条目包含文件：

文件类型：PDF,文件大小：

正在加载全文

未找到全文

浏览次数：77  下载次数：0

分享到：

浏览次数：77

下载次数：0

打印次数：0